You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Oxytetracycline - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for oxytetracycline
Recent Clinical Trials for oxytetracycline

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of OsloN/A
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
Federal University of São PauloPhase 4

See all oxytetracycline clinical trials

Medical Subject Heading (MeSH) Categories for oxytetracycline

US Patents and Regulatory Information for oxytetracycline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TERRAMYCIN oxytetracycline hydrochloride INJECTABLE;INJECTION 060586-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060770-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer TERRAMYCIN W/ POLYMYXIN oxytetracycline hydrochloride; polymyxin b sulfate OINTMENT;OTIC 061841-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer TERRAMYCIN oxytetracycline hydrochloride CAPSULE;ORAL 050286-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Proter OXYTETRACYCLINE HYDROCHLORIDE oxytetracycline hydrochloride CAPSULE;ORAL 060869-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer TERRAMYCIN oxytetracycline calcium SYRUP;ORAL 060595-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Casper Pharma Llc TERRAMYCIN W/ POLYMYXIN B SULFATE oxytetracycline hydrochloride; polymyxin b sulfate OINTMENT;OPHTHALMIC 061015-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.